The Science of Success
The BIA has responded to the Science and Technology Committee’s inquiry on a UK Advanced Research Projects Agency (ARPA).
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2020 to January 2021.
The BIA has written to Lord Hill responding to his call for evidence on the UK's listing rules.
The BIA has submitted to the Government's call for views ahead of the Budget on 3 March 2021.
This report is an exclusive analysis of the performance of the UK-quoted biotech sector and the breadth of its investor base by Radnor Capital Partners on behalf of the BIA.
The BIA has responded to the HM Treasury and HMRC consultation on the scope of qualifying expenditure for R&D tax credits.
The BIA has responded to the UK Intellectual Property Office's call for views on AI and IP.